At present, with the rise of personalized treatment for BC, both the oestrogen receptor and human epidermal growth factor receptor 2 have been confirmed as therapeutic targets for BC, and many BC patients benefit from them [5,6,7,8]. Here, ERBB2 is linked to breast cancer.